Megan McCausland
In her current role, Megan provides customers with guidance on designing state-of-the-art panels to support global clinical trials.
Having joined IQVIA Laboratories in 2013 as an assay development scientist, she has extensive experience in the development, validation and global implementation of multi-parameter flow cytometry assays and led the global deployment of the Cytek Aurora spectral cytometry platform.
Megan holds a BS in Biology from James Madison University in Harrisonburg, Virginia.
ArticleLab of the future: four technologies to watch
From precision proteomics to AI-powered immune profiling, next-generation laboratory technologies are changing how new therapies are discovered and developed. Here are four innovations set to shape the lab of the future - and the future of drug discovery.